With more than 80,000 chemicals currently on the market, and about 700 new ones added each year, a lot is at stake, observers say. The challenge is getting policymakers, Congress, and the courts to accept a new approach—one that would involve shifting from expensive and time-consuming whole-animal studies to in vitro tests with human cell lines.